ArticleCureus2024
A Case of OHVIRA (Obstructed Hemivagina and Ipsilateral Renal Anomaly) Syndrome Diagnosed After Signs of Infection During Pregnancy.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Fertility, Pregnancy, and Psychological Burden in OHVIRA Syndrome: Clinical Case Study and Review of the Literature.Journal of clinical medicine · 2026Article
- Obstructed hemivagina and ipsilateral renal anomaly syndrome: a case series of 4 patients with insights into diagnosis and treatment strategies.AJOG global reports · 2026Article
- Obstructed Hemivagina, Uterine Didelphys, and Ipsilateral Renal Agenesis: A Case Report of OHVIRA Syndrome.Acta medica Lituanica · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome is a rare group of disorders that affects women at all stages of life. These disorders can elicit symptoms such as menstrual molimina and dysmenorrhea during puberty; miscarriage, premature birth, and infertility during childbearing age; and purulent discharge during menopause and old age. In this study, we report our experience with OHVIRA syndrome, which was diagnosed during childbearing age when the patient showed signs of infection during pregnancy. The patient was a 28-year-old female diagnosed with OHVIRA syndrome during pregnancy who had previously undergone a cesarean section. Despite having a normal prenatal period, the patient experienced lower abdominal pain at 27 weeks gestation, prompting urgent hospitalization. Clinical signs suggested chorioamnionitis; however, the amniocentesis results were negative. Computed tomography and magnetic resonance imaging demonstrated unilateral renal agenesis and a duplicated uterus, characteristics of OHVIRA syndrome, in addition to a uterine infection on the non-pregnant side. Antibiotic treatment enabled the pregnancy to continue until an emergency cesarean section was performed at 31 weeks. Surgery confirmed OHVIRA syndrome with incomplete obstruction. This case highlights the challenges that can arise during the perinatal period due to a partially obstructed duplicated uterus. It emphasizes the importance of performing ultrasonographic renal evaluations when assessing uterine malformations, as this can aid in early detection and effective management of women's health, especially during the perinatal period. Despite its rarity, it is crucial for healthcare providers to be aware of OHVIRA syndrome during clinical interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.